ASCO GU Conference Coverage
Filter News By:
Featured Articles
(Medscape Medical News) Feb 17, 2020 - For the first time, a clear cell renal cell carcinoma therapy targets a molecular driver of the cancer that was previously believed to be "undruggable," said investigator Toni Choueiri, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, here at the Genitourinary Cancers Symposium (GUCS)...
Read Article
(MedPage Today) Feb 15, 2020 - Patients with cisplatin-ineligible advanced bladder cancer achieved durable objective responses with the combination of pembrolizumab (Keytruda) and a newly approved antibody-drug conjugate (ADC), new data from a phase I trial showed. Overall, 33 of 45 patients responded to pembrolizumab and enfortumab...
Read Article
Latest Articles
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
February 18, 2020
View More
News Commentary
There is no ASCO GU Conference Coverage commentary.

Featured Videos
There are no ASCO GU Conference Coverage videos.
OBR Blog
There are no ASCO GU Conference Coverage blog entries.

OBR Tweets

May 30
Pfizer Shares Fall After-Hours After Suspension Of Cancer Study #ASCO20 https://t.co/kkMwIf4371

May 30
Genentech: FDA Approves Tecentriq in Combination With Avastin for Some Liver Cancer Patients #ASCO20 https://t.co/PZv8m8CUvk

May 30
Katie Kelley, MD, of @UCSF discusses fitting tremelimumab + durvalumab into HCC treatment algorithms #ASCO20 https://t.co/PgkmKoeVoz

May 30
Nicholas Vogelzang, MD, FAC, FASCO, of @CCCNevada explains how cabazitaxel should be used in various lines of treat… https://t.co/WAkWkUFmEf

May 30
Vivek Subbiah @VivekSubbiah , MD, of @MDAndersonNews on the FDA approved product, selpercatanib, for RET-driven lu… https://t.co/ILwAZtxXfh

May 30
Final Prosper Results Show Xtandi® (Enzalutamide) Significantly Extends Overall Survival In Men With Non-Metastatic… https://t.co/BobQ15CZOj

May 30
SPEAR T-cells Targeting MAGE-A4 Demonstrate New Responses in Esophagogastric Junction (EGJ), Lung, and Head and Nec… https://t.co/UKu93KJpLA

May 30
Vivek Subbiah @VivekSubbiah , MD, @MDAndersonNews describes solid tumor tests for RET fusion and similarities it m… https://t.co/9MlHzs422k

May 30
Saad Usmani @szusmani, MD, of @LevineCancer outlines the Phase 1 study investigating teclistamab in relapsed/refrac… https://t.co/ODs1HrnftW

May 30
Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early… https://t.co/LM1kg7cgcx